VC fund profile · evidence-aware directory data
Janus Henderson Investors stages, portfolio and investment profile
Janus Henderson Investors co-led Star Therapeutics' $200M private financing announced on October 23, 2026, alongside OrbiMed. Vish Sridharan, assistant portfolio manager and research analyst, is joining Star as a board observer. In Star's announcement, Sridharan said the firm does not often invest at this development stage and emphasized the team's ability to identify therapeutic opportunities and develop medicines. The announcement did not disclose Janus Henderson's individual allocation or a Star valuation. This participation should not be interpreted as an independently validated clinical outcome.
Keep track of Janus Henderson Investors
Save this profile to your VCT watchlist for a quick return.
Stage-based planning range
$100K–$1M
This is a planning range inferred from stage coverage, not a firm-disclosed check size.
Methodology: Stage bucket inferred from the rounds a fund leads or invests in.
No firm-specific check-size disclosure is recorded.
Investment stages
Leads: Not recorded
Participates: Not recorded
Sector focus
Not recorded
Geography
Not recorded
Founded Not recorded
Fund size / AUM
Not recorded
A separate fund-size evidence record is not yet available.
Portfolio in our directory
1
Linked startup profiles
Latest fund vehicle
Not recorded
Vehicle name, size, and vintage are not yet structured.
Recent tracked investment
Not recorded
No dated round explicitly links this fund.
Rounds they lead
Rounds they invest
Last verified: 2026-10-24. Check-size evidence is labeled by basis so planning estimates are not presented as firm disclosures.
Portfolio companies we track
Startups in our directory that list Janus Henderson Investors as an investor (1 total).
Related investment articles
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.